Connect with us

Health

Moderna lowers forecast for 2021 COVID-19 vaccine deliveries – CP24 Toronto's Breaking News

Published

 on


Moderna is scaling back expectations for the number of COVID-19 vaccine deliveries it expects to make this year and the revenue it will record from them.

Issues including longer delivery lead times for exports and a temporary impact from expanding the company’s capacity to fill vials with vaccine and package them for shipping, which may shift some deliveries to early 2022, the drugmaker said Thursday. The company now expects full-year, 2021 product sales of between $15 billion and $18 billion.

That’s down from a prediction for $20 billion in sales that it made in August.

CEO Stephane Bancel told analysts on Thursday that his company’s issues stemmed from scaling up production so quickly. He also said the problems are short-term and can be fixed.

“Our supply chain became more complex with increased deliveries to countries around the world,” Bancel said.

Moderna‘s work on expanding its capacity is complete and it should see a “positive impact” from that soon, Bancel said.

The company now expects to deliver between 700 million to 800 million doses this year, down from a previous forecast for 800 million to 1 billion.

Moderna‘s COVID-19 vaccine is the drugmaker’s only product on the market. It’s also developing and testing several other vaccines including a combination that protects against both COVID-19 and the flu.

The COVID-19 vaccine brought in $4.81 billion in sales during Moderna‘s third quarter, which fell well short of analyst expectations overall.

The Cambridge, Massachusetts, company earned $3.3 billion on about $5 billion in total revenue, which includes some grants and collaboration revenue. Earnings per share totaled $7.70.

Analysts expected $9.09 per share on $6.2 billion in revenue, according to FactSet.

Company shares tumbled 19% to $280.14 Thursday afternoon, still two and a half times higher than the stock’s price at the start of the year.

Moderna Inc. makes one of three COVID-19 vaccines currently being used in the United States to fight the pandemic. The others are made by Pfizer Inc. and Johnson & Johnson.

Next year, Moderna expects to pick up production and will be able to make 3 billion doses of its vaccine if needed, Bancel said.

The company expect 2022 revenue to range between $17 billion and $22 billion, with the market for COVID-19 booster shots in the U.S. next fall totaling up to $2 billion.

Analysts expect, on average, about $21.38 billion in revenue, according to FactSet.

Moderna has an emergency use authorization for the vaccine in adults but is still waiting for U.S. regulators to grant a similar authorization for 12- to 17-year olds. Regulators are studying the rare risk of a heart inflammation that has shown up in some people who have received the shots.

The company said recently that review could last until January.

An analyst asked Moderna executives on Thursday why regulators seem more concerned about this risk from their vaccine in younger age groups than from Pfizer’s shot, which is already authorized for adolescents.

Moderna President Dr. Stephen Hoge said it was mostly a matter of timing.

Hoge noted that Pfizer’s vaccine was authorized before there was any “substantial discussion” of the condition as a risk. He added that Moderna‘s shots have already been approved for that age group in several countries, and their global database of 1.5 million people below age 18 who have received their vaccination does not show an increased risk of the issue.

“We think over time the substantial benefits of our vaccine will ultimately win out,” Hoge said.

Adblock test (Why?)



Source link

Continue Reading

Health

Tougher COVID-19 measures in Sudbury/Manitoulin districts – My Eespanola Now

Published

 on





The Medical Officer of Health for Public Health Sudbury & Districts is reinstating work-from-home requirements.

Dr Penny Sutcliffe also says strong recommendations for COVID-19 protections are being issued to area schools, businesses, and organizations and stricter measures for the follow-up of contacts of cases of COVID-19 are being enacted.

Public Health is reissuing its call to everyone to continue to limit outings, work from home, get vaccinated, wear a mask and keep two metres distance from those outside your household.

They say continued high COVID19 rates mean that the Public Health Sudbury & Districts area is among the top three most affected jurisdictions in Ontario.

As of Friday, the agency had 288 active cases with Health Sciences North reporting 38 admitted patients with seven in intensive care.

Adblock test (Why?)



Source link

Continue Reading

Health

First children's vaccination clinic in Chatham fully booked – BlackburnNews.com

Published

 on


First children’s vaccination clinic in Chatham fully booked

10-year-old Lucy Gillette from Chatham was the first to receive a COVID-19 vaccine at the Bradley Centre Clinic in Chatham on Saturday, November 27, 2021. (Photo courtesy of CKPHU)

Lucy Gillette, age 10, Chatham


Hundreds of Band-Aids were plastered onto the little arms of kids in Chatham-Kent who rolled up their sleeves for their first COVID-19 vaccine.

Chatham-Kent Public Health Unit (CKPHU) says 550 doses were administered to children aged five to 11 on Saturday for the first day of the municipality’s pediatric vaccination campaign.

“Things went really well and there has been a lot of excitement,” said Jeff Moco with Chatham-Kent Public Health Communications. “People seem to be excited to start this next phase of the vaccination campaign.”

Appointments for Pfizer-BioNTech’s pediatric vaccine at the Bradley Centre in Chatham opened on Tuesday, November 23.

The clinic has been transformed into a youth-friendly vaccination clinic with a “Super-Kid” theme that includes bright colours, balloons, and costumes.

“It has a different vibe, we have the balloons and the superhero theme,” said Moco. “It’s a lot of fun and lighthearted.”

The vaccination clinic at the Bradley Centre will run Tuesday to Saturday from 3 p.m. to 7 p.m. Moco said another clinic has been added this Monday, which has a lot of spaces still available.

There are also three vaccine clinics planned at schools beginning next month.

The school clinics will be at Blenheim District Secondary School on December 6, 2021, Wallaceburg District Secondary School on December 13, and Tilbury District Secondary School on December 20.

All school clinics run from 3 p.m. until 8 p.m. and everyone is welcome to get the shot at those clinics.

“I don’t think any kid likes getting a vaccination but what we have been hearing is that they see other people in their lives get vaccinated and feel left out,” said Moco. “Some of them have been interested in doing their part and it’s kind of neat seeing that mindset in young people.”

Adblock test (Why?)



Source link

Continue Reading

Health

Kids COVID vaccine campaign ramps up in the capital amid concerns over new variant – CTV Edmonton

Published

 on


OTTAWA —
Ottawa’s COVID-19 vaccination campaign for children ramped up on Saturday as thousands of kids between 5 and 11-years-old rolled up their sleeves for their first shot.

All seven of Ottawa’s community vaccination clinics are now offering paediatric doses this weekend.

The push to immunize as many as possible has been amplified by concerns over a new variant emerging from southern Africa.

Ottawa’s clinics were running full speed Saturday; there were lineups outside some sites.

“A lot of relief that we’re finally able to get the shots in the kiddos and excited about the next one,” said Toufic Zayoun, after their kids received the first shot.

More than 1,400 doses were administered Friday to kids between 5 and 11 in the capital. As of Friday afternoon, Ottawa Public Health said nearly 5,000 appointments had been booked for the first weekend.

This comes though as concerns of a new COVID variant emerge. The Omicron variant, first detected in southern Africa, appears to be more transmissible.

“I think it’s too early to panic,” said Dr. Kwadwo Kyeremanteng, an Ottawa critical care physician.

“We haven’t had any solid data to show it could evade the vaccine, it’s hard to gauge how it would respond in our setting where we have extremely good vaccination rates.”

For now, Dr. Kyeremanteng is pushing for continued caution and encourages immunization.

“To me the message that’s loud and clear right now is we need to think about global vaccinations very seriously,” he said.

The new variant of concern is already on the minds of parents too.

“Any new variant that comes up is always concerning and it’s just nice to have that extra layer of protection for the kids now too,” said Christie Cowan, after her two kids got their first shot Saturday.

She’s hopeful increased immunization will mean a more normal heart ahead for kids in the capital.

“If this means schools stay open, especially after Christmas, this means everything to them,” said Cowan.

Adblock test (Why?)



Source link

Continue Reading

Trending